Yes. For much of the day the near term buying depth was five times the near term selling depth.
With results due soon, and the snippets of data looking very good and deal negotiations happening I'm surprised this biotech hasn't gone bananas like so many have recently. This one has real substance to it!
But with a 10% increase on good volumes today maybe it'll get noticed.